Examining the Truvada #BreakThePatent Debate: Gilead Responds
Major Win for Patients as Brazil Rejects a Key Patent on Gilead Hepatitis C Drug and European Court of Justice Opinion Denies Patent Extension to Gilead’s HIV Drug
Patent war: patients vs profit – Tahir Amin Discusses the Recent Novartis Decision on NDTV
Update on I-MAK’s patent observations against Abbott Laboratories in Europe
Brazilian Patent Office Rejects Gilead’s Divisional Application for Tenofovir Disoproxil Fumarate
Abbott Abandons Several Patent Applications in India
India Rejects Patent Application by Abbott for Lifesaving HIV Drug
US Government’s Interference in India’s Tenofovir Proceedings
HIV Drug Patent Landscape in China
India Rejects Gilead’s Tenofovir Patent Applications